ScholarLens Back to search
2013•Molecular ImmunologyRequires access

Complement-dependent cytotoxicity exerted by two therapeutic anti-CD20 mAbs: Rituximab and ofatumumab in human B-cell malignant cell lines and primary cultures

Marcin Okrój, I. Eriksson, Anders Österborg, Anna M. Blom

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Ofatumumab, CD20, Complement-dependent cytotoxicity, Rituximab, Cytotoxicity, Complement (music), Cancer research, Chemistry

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Complement-dependent cytotoxicity exerted by two therapeutic anti-CD20 mAbs: Rituximab and ofatumumab in human B-cell malignant cell lines and primary cultures — Research Paper | ScholarLens